Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 660

1.

Hemolytic uremic syndrome in a developing country: Consensus guidelines.

Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J, Patnaik SK, Sinha A, Sethi S, Hari P, Dragon-Durey MA; Indian Society of Pediatric Nephrology.

Pediatr Nephrol. 2019 Apr 15. doi: 10.1007/s00467-019-04233-7. [Epub ahead of print]

PMID:
30989342
2.

[HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].

Mancini A, Ardissino G, Angelini P, Giancaspro V, La Raia E, Nisi M, Proscia A, Tarantino G, Vitale O, D'elia F.

G Ital Nefrol. 2019 Apr;36(2). pii: 2019-vol2. Italian.

PMID:
30983177
3.

Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.

Le Clech A, Simon-Tillaux N, Provôt F, Delmas Y, Vieira-Martins P, Limou S, Halimi JM, Le Quintrec M, Lebourg L, Grangé S, Karras A, Ribes D, Jourde-Chiche N, Rondeau E, Frémeaux-Bacchi V, Fakhouri F.

Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30165-6. doi: 10.1016/j.kint.2019.01.023. [Epub ahead of print]

PMID:
30982675
4.

Elevated plasma levels of soluble C-type lectin-like receptor 2 (CLEC2) in patients with thrombotic microangiopathy.

Yamashita Y, Suzuki K, Mastumoto T, Ikejiri M, Ohishi K, Katayama N, Suzuki-Inoue K, Wada H.

Thromb Res. 2019 Mar 28;178:54-58. doi: 10.1016/j.thromres.2019.03.018. [Epub ahead of print]

PMID:
30978634
5.

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study.

Menne J, Delmas Y, Fakhouri F, Licht C, Lommelé Å, Minetti EE, Provôt F, Rondeau E, Sheerin NS, Wang J, Weekers LE, Greenbaum LA.

BMC Nephrol. 2019 Apr 10;20(1):125. doi: 10.1186/s12882-019-1314-1.

6.

Typical or Atypical Hemolytic Uremic Syndrome and the Use of Eculizumab: 4 Illustrative Cases.

de Ville de Goyet M, Detaille T, Godefroid N.

J Pediatr Hematol Oncol. 2019 Mar 29. doi: 10.1097/MPH.0000000000001449. [Epub ahead of print]

PMID:
30933023
7.

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome.

Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ; Global aHUS Registry.

Kidney Int Rep. 2018 Dec 3;4(3):434-446. doi: 10.1016/j.ekir.2018.11.010. eCollection 2019 Mar.

8.

Postpartum Renal Cortical Necrosis Is Associated With Atypical Hemolytic Uremic Syndrome in Developing Countries.

Ramachandran R, Nayak S, Anakutti HP, Yadav AK, Nada R, Jain V, Gupta KL, Jha V.

Kidney Int Rep. 2018 Nov 28;4(3):420-424. doi: 10.1016/j.ekir.2018.11.012. eCollection 2019 Mar.

9.

Hemolytic Uremic Syndrome in an Infant with Primary Hyperoxaluria Type II: An Unreported Clinical Association.

Valoti E, Alberti M, Carrara C, Breno M, Yilmaz Keskin E, Bresin E, Cuccarolo P, Açikgöz Y, Benigni A, Noris M, Remuzzi G, Mele C.

Nephron. 2019 Mar 19:1-7. doi: 10.1159/000497823. [Epub ahead of print]

PMID:
30889567
10.

Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition.

Hanna RM, Barsoum M, Vandross A, Kurtz I, Burwick R.

Curr Opin Nephrol Hypertens. 2019 May;28(3):278-287. doi: 10.1097/MNH.0000000000000499.

PMID:
30865166
11.

Elevated Systemic Pentraxin-3 Is Associated With Complement Consumption in the Acute Phase of Thrombotic Microangiopathies.

Trojnar E, Józsi M, Szabó Z, Réti M, Farkas P, Kelen K, Reusz GS, Szabó AJ, Garam N, Mikes B, Sinkovits G, Mező B, Csuka D, Prohászka Z.

Front Immunol. 2019 Feb 25;10:240. doi: 10.3389/fimmu.2019.00240. eCollection 2019.

12.

Chronic Neurological Complications in Hemolytic Uremic Syndrome in Children.

Tavasoli A, Zafaranloo N, Hoseini R, Otukesh H, Hooman N, Panahi P.

Iran J Kidney Dis. 2019 Jan;13(1):32-35.

13.

Seizure as the Presenting Symptom for Atypical Hemolytic Uremic Syndrome.

Chan S, Weinstein AR.

J Emerg Med. 2019 Apr;56(4):441-443. doi: 10.1016/j.jemermed.2018.12.034. Epub 2019 Feb 27.

PMID:
30826084
14.

[The unusual couple: a clinical case of coexistence between aHUS and Fabry's disease].

Coppola S, Cuomo V, Riccio CG, d'Apice L, de Simone W, Capasso G.

G Ital Nefrol. 2019 Feb;36(1). pii: 2019-vol1. Italian.

PMID:
30758152
15.

Atypical hemolytic-uremic syndrome as one of the causes of acute kidney injury in pregnant women.

Kozlovskaya NL, Korotchaeva YV, Shifman EM, Bobrova LA.

Ter Arkh. 2018 Jun 20;90(6):28-34. doi: 10.26442/terarkh201890628-34.

PMID:
30701901
16.

Atypical hemolytic-uremic syndrome: recurrent phenotypic expression of a patient with MCP gene mutation combined with risk haplotypes.

Marini SC, Gomes M, Guilherme R, Carda JP, Pinto CS, Fidalgo T, Ribeiro ML.

Blood Coagul Fibrinolysis. 2019 Mar;30(2):68-70. doi: 10.1097/MBC.0000000000000793.

PMID:
30676336
17.

Complement Gene Variants and Shiga Toxin-Producing Escherichia coli-Associated Hemolytic Uremic Syndrome: Retrospective Genetic and Clinical Study.

Frémeaux-Bacchi V, Sellier-Leclerc AL, Vieira-Martins P, Limou S, Kwon T, Lahoche A, Novo R, Llanas B, Nobili F, Roussey G, Cailliez M, Ulinski T, Deschênes G, Alberti C, Weill FX, Mariani P, Loirat C.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):364-377. doi: 10.2215/CJN.05830518. Epub 2019 Jan 23.

PMID:
30674459
19.

Therapeutic Plasma Exchange in Pediatric Renal Transplantation Experience of One Decade and 389 Sessions.

Runowski D, Prokurat S, Rubik J, Grenda R.

Transplant Proc. 2018 Dec;50(10):3483-3486. doi: 10.1016/j.transproceed.2018.07.015. Epub 2018 Jul 10.

PMID:
30577225
20.

Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases.

Bianchi L, Gaiani F, Vincenzi F, Kayali S, Di Mario F, Leandro G, De' Angelis GL, Ruberto C.

Acta Biomed. 2018 Dec 17;89(9-S):153-157. doi: 10.23750/abm.v89i9-S.7911.

PMID:
30561409

Supplemental Content

Loading ...
Support Center